Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 Sep 7;2011(9):CD008012.
doi: 10.1002/14651858.CD008012.pub3.

Psychological and pharmacological interventions for depression in patients with coronary artery disease

Harald Baumeister  1 , Nico Hutter, Jürgen Bengel
Affiliations
Meta-Analysis

Psychological and pharmacological interventions for depression in patients with coronary artery disease

Harald Baumeister et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: Depression occurs frequently in patients with coronary artery disease (CAD) and is associated with a poor prognosis.

Objectives: To determine the effects of psychological and pharmacological interventions for depression in CAD patients with comorbid depression.

Search strategy: CENTRAL, DARE, HTA and EED on The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL, ISRCTN Register and CardioSource Registry were searched. Reference lists of included randomised controlled trials (RCTs) were examined and primary authors contacted. No language restrictions were applied.

Selection criteria: RCTs investigating psychological and pharmacological interventions for depression in adults with CAD and comorbid depression were included. Primary outcomes were depression, mortality and cardiac events. Secondary outcomes were healthcare costs and health-related quality of life (QoL).

Data collection and analysis: Two reviewers independently examined the identified papers for inclusion and extracted data from included studies. Random effects model meta-analyses were performed to compute overall estimates of treatment outcomes.

Main results: The database search identified 3,253 references. Sixteen trials fulfilled the inclusion criteria. Psychological interventions show a small beneficial effect on depression compared to usual care (range of SMD of depression scores across trials and time frames: -0.81;0.12). Based on one trial per outcome, no beneficial effects on mortality rates, cardiac events, cardiovascular hospitalizations and QoL were found, except for the psychosocial dimension of QoL. Furthermore, no differences on treatment outcomes were found between the varying psychological approaches. The review provides evidence of a small beneficial effect of pharmacological interventions with selective serotonin reuptake inhibitors (SSRIs) compared to placebo on depression outcomes (pooled SMD of short term depression change scores: -0.24 [-0.38,-0.09]; pooled OR of short term depression remission: 1.80 [1.18,2.74]). Based on one to three trials per outcome, no beneficial effects regarding mortality, cardiac events and QoL were found. Hospitalization rates (pooled OR of three trials: 0.58 [0.39,0.85] and emergency room visits (OR of one trial: 0.58 [0.34,1.00]) were reduced in trials of pharmacological interventions compared to placebo. No evidence of a superior effect of Paroxetine (SSRI) versus Nortriptyline (TCA) regarding depression outcomes was found in one trial.

Authors' conclusions: Psychological interventions and pharmacological interventions with SSRIs may have a small yet clinically meaningful effect on depression outcomes in CAD patients. No beneficial effects on the reduction of mortality rates and cardiac events were found. Overall, however, the evidence is sparse due to the low number of high quality trials per outcome and the heterogeneity of examined populations and interventions.

PubMed Disclaimer

Conflict of interest statement

None known

Figures

1
1
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Psychological Intervention vs. Usual Care, Outcome 1 Depression score ‐ short term.
1.2
1.2. Analysis
Comparison 1 Psychological Intervention vs. Usual Care, Outcome 2 Depression score ‐ medium term.
1.3
1.3. Analysis
Comparison 1 Psychological Intervention vs. Usual Care, Outcome 3 Depression score ‐ long term.
1.4
1.4. Analysis
Comparison 1 Psychological Intervention vs. Usual Care, Outcome 4 Depression remission ‐ short, medium and long term.
1.5
1.5. Analysis
Comparison 1 Psychological Intervention vs. Usual Care, Outcome 5 Mortality, cardiac events and cardiovascular hospitalizations.
1.6
1.6. Analysis
Comparison 1 Psychological Intervention vs. Usual Care, Outcome 6 Quality of life ‐ short term.
1.7
1.7. Analysis
Comparison 1 Psychological Intervention vs. Usual Care, Outcome 7 Quality of life ‐ medium term.
1.8
1.8. Analysis
Comparison 1 Psychological Intervention vs. Usual Care, Outcome 8 Quality of life ‐ long term.
2.1
2.1. Analysis
Comparison 2 Psychological Intervention vs. Psychological Intervention / Clinical Managmement, Outcome 1 Depression score ‐ short term.
2.2
2.2. Analysis
Comparison 2 Psychological Intervention vs. Psychological Intervention / Clinical Managmement, Outcome 2 Depression score ‐ medium term.
2.3
2.3. Analysis
Comparison 2 Psychological Intervention vs. Psychological Intervention / Clinical Managmement, Outcome 3 Depression score ‐ long term.
2.4
2.4. Analysis
Comparison 2 Psychological Intervention vs. Psychological Intervention / Clinical Managmement, Outcome 4 Depression remission ‐ short term.
2.5
2.5. Analysis
Comparison 2 Psychological Intervention vs. Psychological Intervention / Clinical Managmement, Outcome 5 Depression remission ‐ medium and long term.
2.6
2.6. Analysis
Comparison 2 Psychological Intervention vs. Psychological Intervention / Clinical Managmement, Outcome 6 Cardiac events.
2.7
2.7. Analysis
Comparison 2 Psychological Intervention vs. Psychological Intervention / Clinical Managmement, Outcome 7 Quality of life.
3.1
3.1. Analysis
Comparison 3 Pharmacological Intervention vs. Placebo, Outcome 1 Depression score ‐ short term.
3.2
3.2. Analysis
Comparison 3 Pharmacological Intervention vs. Placebo, Outcome 2 Depression remission ‐ short term.
3.3
3.3. Analysis
Comparison 3 Pharmacological Intervention vs. Placebo, Outcome 3 All‐cause mortality.
3.4
3.4. Analysis
Comparison 3 Pharmacological Intervention vs. Placebo, Outcome 4 Cardiac events.
3.5
3.5. Analysis
Comparison 3 Pharmacological Intervention vs. Placebo, Outcome 5 Resource utilization.
3.6
3.6. Analysis
Comparison 3 Pharmacological Intervention vs. Placebo, Outcome 6 Healthcare costs.
3.7
3.7. Analysis
Comparison 3 Pharmacological Intervention vs. Placebo, Outcome 7 Quality of life ‐ short term.
4.1
4.1. Analysis
Comparison 4 Pharmacological Intervention vs. Pharmacological Intervention, Outcome 1 Depression score ‐ short term.
4.2
4.2. Analysis
Comparison 4 Pharmacological Intervention vs. Pharmacological Intervention, Outcome 2 Depression remission ‐ short term.
See this image and copyright information in PMC

Comment in

References

References to studies included in this review

Barth 2005 {published and unpublished data}
    1. Barth J, Paul J, Härter M, Bengel J. Inpatient psychotherapeutic treatment for cardiac patients with depression in Germany: short‐term results. GMS Psycho‐Social‐Medicine 2005;2:1‐8. - PMC - PubMed
Brown 1993 {published data only (unpublished sought but not used)}
    1. Brown MA, Munford AM, Munford PR. Behavior therapy of psychological distress in patients after myocardial infarction or coronary bypass. Journal of Cardiopulmonary Rehabilitation and Prevention 1993;13:201‐10.
CREATE 2007 {published data only}
    1. Frasure‐Smith N, Koszycki D, Swenson JR, Baker B, Zyl L. Design and Rationale for a Randomized, Controlled Trial of Interpersonal Psychotherapy and Citalopram for Depression in Coronary Artery Disease (CREATE): Erratum. Psychosomatic Medicine 2007;69(2):216. - PubMed
    1. Frasure‐Smith N, Koszycki D, Swenson JR, Baker B, Zyl LT, Laliberté MA, et al. Design and rationale for a randomized, controlled trial of interpersonal psychotherapy and citalopram for depression in coronary artery disease (CREATE). Psychosomatic Medicine 2006;68:87‐93. - PubMed
    1. Lespérance F, Frasure‐Smith N, Koszycki D, Laliberté MA, Zyl LT, Baker B, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007;29:367‐79. - PubMed
    1. Zyl LT, Lesperance F, Frasure‐Smith N, Malinin AI, Atar D, Laliberte MA, et al. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub‐study. Journal of Thrombosis & Thrombolysis 2009;27(1):48‐56. - PubMed
Doering 2007 {published data only (unpublished sought but not used)}
    1. Doering LV, Cross R, Vredevoe D, Martinez‐Maza O, Cowan MJ. Infection, depression, and immunity in women after coronary artery bypass: a pilot study of cognitive behavioral therapy. Alternative Therapies in Health and Medicine 2007;13:18‐21. - PubMed
ENRICHD 2003 {published data only (unpublished sought but not used)}
    1. Berkman LF, Blumenthal J, Burg M, Carney RM, Catellier D, Cowan MJ, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106‐16. - PubMed
    1. ENRICHD Investigators. Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. Psychosomatic Medicine 2001;63(5):747‐55. - PubMed
    1. ENRICHD Investigators. Enhancing recovery in coronary heart disease (ENRICHD): baseline characteristics. The American Journal of Cardiology 2001;88(3):316‐22. - PubMed
    1. ENRICHD Investigators. Enhancing recovery in coronary heart disease patients (ENRICHD): study design and methods. American Heart Journal 2000;139:1‐9. - PubMed
    1. Mendes de Leon CF, Czajkowski SM, Freedland KE, Bang H, Powell LH, Wu C, et al. The effect of a psychosocial intervention and quality of life after acute myocardial infarction: the Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial. Journal of Cardiopulmonary Rehabilitation 2006;26:9‐13. - PubMed
Fang 2003 {published data only}
    1. Fang R, Jiang Y, Song J, Cheng G, Xue G. Control study of general psychological intervention for patients with myocardial infarction [Chinese]. Chinese Journal of Clinical Rehabilitation 2003;7:1382‐3.
Freedland 2009 {published data only}
    1. Freedland KE. Treatment of depression after coronary bypass surgery. http://www.controlled‐trials.com/mrct/trial/438737 (accessed 14 December 2009).
    1. Freedland KE, Skala JA, Carney RM, Rubin EH, Lustman PJ, Dávila‐Roman VG, et al. Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Archives of General Psychiatry 2009;66:387‐96. - PMC - PubMed
Freeman 1986 {published data only (unpublished sought but not used)}
    1. Freeman AM, Fleece L, Folks DG, Sokol RS, Hall KR, Pacifico AD, et al. Alprazolam treatment of postcoronary bypass anxiety and depression. Journal of Clinical Psychopharmacology 1986;6:39‐41. - PubMed
Li 2005 {published data only}
    1. Li YM, Li GY, Wang XL, Yu LF. Rehabilitation effect of San John's Wort extract on depression and myocardial function after coronary artery bypass grafting: a randomized grouping, placebo‐control and blind evaluation [Chinese]. Zhongguo Linchuang Kangfu 2005;9:38‐9.
Liu 1999 {published data only}
    1. Liu JD, Zheng H. Efficacy of fluoxetine in the treatment of depression in patients with acute myocardial infarction [Chinese]. Journal of Clinical Psychological Medicine 1999;9:210‐1.
McFarlane 2001 {published data only (unpublished sought but not used)}
    1. McFarlane A, Kamath MV, Fallen EL, Malcolm V, Cherian F, Norman G. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. American Heart Journal 2001;142(4):617‐23. - PubMed
McLaughlin 2005 {published data only (unpublished sought but not used)}
    1. Bambauer KZ, Aupont O, Stone PH, Locke SE, Mullan MG, Colagiovanni J, et al. The effect of a telephone counseling intervention on self‐rated health of cardiac patients. Psychosomatic Medicine 2005;67:539‐45. - PubMed
    1. McLaughlin TJ, Aupont O, Bambauer KZ, Stone P, Mullan MG, Colagiovanni J. Improving psychologic adjustment to chronic illness in cardiac patients: the role of depression and anxiety. Journal of General Internal Medicine 2005;20:1084‐90. - PMC - PubMed
MIND‐IT 2007 {published data only (unpublished sought but not used)}
    1. Honig A, Kuyper AM, Schene AH, Melle JP, Jonge P, Tulner DM, et al. Treatment of post‐myocardial infarction depressive disorder: a randomized, placebo‐controlled trial with mirtazapine. Psychosomatic Medicine 2007;69:606‐13. - PubMed
    1. Schins A, Hamuly KK, Scharp S, Lousberg R, Melle J, Crijns H, et al. Whole blood serotonin and platelet activation in depressed post‐myocardial infarction patients. Life Sciences 2004;76(6):637‐50. - PubMed
    1. Melle JP, Jonge P, Honig A, Schene AH, Kuyper AM, Crijns HJ, et al. Effects of antidepressant treatment following myocardial infarction. The British Journal of Psychiatry 2007;190:460‐6. - PubMed
    1. Brink RH, Melle JP, Honig A, Schene AH, Crijns HJ, Lambert FP, et al. Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression‐Intervention Trial (MIND‐IT). American Heart Journal 2002;144:219‐25. - PubMed
Roose 1998 {published data only (unpublished sought but not used)}
    1. Nelson JC, Kennedy JS, Pollock BG, Laghrissi‐Thode F, Narayan M, Nobler MS, et al. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. The American Journal of Psychiatry 1999;156:1024‐8. - PubMed
    1. Pollock BG, Laghrissi‐Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology 2000;20(2):137‐40. - PubMed
    1. Roose S, Pollock B, Kennedy J, Nelson J, Gergel I, McCafferty J. Paroxetine in the treatment of depressed patients with ischaemic heart disease. Sixth World Congress of Biological Psychiatry, Nice, France. June 22 27. 1997.
    1. Roose S, Pollock B, Kennedy J, Nelson J, McCafferty J, Gergel I. Paroxetine versus nortriptyline in ischemic disease. 150th Annual Meeting of the American Psychiatric Association San Diego, California, USA 17 22 May. 1997.
    1. Roose SP, Laghrissi‐Thode F, Kennedy JS, Nelson JC, Bigger JT, Pollock BG, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287‐91. - PubMed
SADHART 2002 {published data only (unpublished sought but not used)}
    1. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701‐9. - PubMed
    1. Glassman AH, O'Connor CM, Califf RM, Swedberg K, Schwartz P, Bigger JT Jr, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina: ERRATUM. JAMA: The Journal of the American Medical Association 2002;288(14):1720. - PubMed
    1. Lattanzio F, Cherubini A, Furneri G, Bari M, Marchionni N. Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System. Aging‐Clinical & Experimental Research 2008;20(1):76‐80. - PubMed
    1. O'Connor CM, Glassman AH, Harrison DJ. Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. The Journal of Clinical Psychiatry 2005;66:346‐52. - PubMed
    1. Serebruany VL, Glassman AH, Malinin AI, Nemeroff CB, Musselman DL, Zyl LT, et al. Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy. Circulation 2003;108(8):939‐44. - PubMed
Strik 2000 {published data only (unpublished sought but not used)}
    1. Strik JJ, Honig A, Klinkenberg E, Dijkstra J, Jolles J. Cognitive performance following fluoxetine treatment in depressed patients post myocardial infarction. Acta Neuropsychiatrica 2006;18(1):1‐6. - PubMed
    1. Strik JJ, Honig A, Lousberg R, Lousberg AH, Cheriex EC, Tuynman‐Qua HG, et al. Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double‐blind, placebo‐controlled trial. Psychosomatic Medicine 2000;62:783‐9. - PubMed
    1. Strik JJ, Praag HM, Honig A. Depression after first myocardial infarction. A prospective study on incidence, prognosis, risk factors and treatment. Tijdschrift Voor Gerontologie en Geriatrie 2003;34(3):104‐12. - PubMed

References to studies excluded from this review

Black 1998 {published data only}
    1. Black JL, Allison TG, Williams DE, Rummans TA, Gau GT. Effect of intervention for psychological distress on rehospitalization rates in cardiac rehabilitation patients. Psychosomatics 1998;39:134‐43. - PubMed
Bucknall 1988 {published data only}
    1. Bucknall C, Brooks D, Curry PVL, Bridges PK, Bouras N, Ankier SI. Mianserin and trazodone for cardiac patients with depression. European Journal of Clinical Pharmacology 1988;33:565‐9. - PubMed
Davidson 2010 {published data only}
    1. Burg MM, Lespérance F, Rieckmann N, Clemow L, Skotzko C, Davidson KW. Treating persistent depressive symptoms in post‐ACS patients: the project COPES phase‐I randomized controlled trial. Contemporary Clinical Trials 2008;29:231‐40. - PMC - PubMed
    1. Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V, et al. Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms. Archives of Internal Medicine 2010;170:600‐8. - PMC - PubMed
Fu 2006 {published data only}
    1. Fu YX, Meng HQ, Luo QH. Interventional effect of fluoxetine on patients with acute myocardial infarction accompanied by anxiety and depression [Chinese]. Chinese Journal of Clinical Rehabilitation 2006;10:16‐7.
González‐Jaimes 2003 {published data only}
    1. Gonzalez‐Jaimes EI, Turnbull‐Plaza B. Selection of psychotherapeutic treatment for adjustment disorder with depressive mood due to acute myocardial infarction. Archives of Medical Research 2003;34:298‐304. - PubMed
Kachkovskii 2006 {published data only}
    1. Kachkovskii MA, Kriukov NN. Treatment of depression in patients with myocardial infarction with tianeptine [Russian]. Kardiologiia 2006;46:21‐6. - PubMed
Mohapatra 2005 {published data only}
    1. Mohapatra PK, Kar N, Kar GC, Behera M. Effectiveness of sertraline in treatment of depression in a consecutive sample of patients with acute myocardial infarction: six month prospective study on outcome. Clinical Practice and Epidemiology in Mental Health 2005;1:26. - PMC - PubMed
Norris 2009 {published data only}
    1. Norris CE, Patterson L, Galbraith D, Hegadoren KM. All you have to do is call; a pilot study to improve the outcomes of patients with coronary artery disease. Applied Nursing Research 2009;22:133‐7. - PubMed
Oldridge 1991 {published data only}
    1. Oldridge N, Guyatt G, Jones N, Crowe J, Singer J, Feeny D, et al. Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. The American Journal of Cardiology 1991;67:1084‐9. - PubMed
    1. Oldridge N, Streiner D, Hoffmann R, Guyatt G. Profile of mood states and cardiac rehabilitation after acute myocardial infarction. Medicine and Science in Sports and Exercise 1995;27:900‐5. - PubMed
Pogosova 2004 {published data only}
    1. Pogosova GV, Zhidko NI, Krasnitsky VB, Tikhomirova EA, Odintsova AS, Akhmedjanov NM, et al. Clinical efficacy of tianeptine in patients with ischemic heart disease and comorbid depression [Russian]. Kardiologiia 2004;44:20‐4. - PubMed
Pogosova 2009 {published data only}
    1. Pogosova GV, Koltunov IE, Karpova AV, Eliseeva NA, Sapunova ID. Clinical efficacy of escitalopram in patients with ischemic heart disease and comorbid depression [Russian]. Kardiologiia 2009;49:4‐8. - PubMed
Rollman 2009 {published data only}
    1. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, et al. Telephone‐delivered collaborative care for treating post‐CABG depression: a randomized controlled trial. JAMA 2009;302:2095‐103. - PMC - PubMed
    1. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Schulberg HC, Reynolds CF III. The Bypassing the Blues treatment protocol: stepped collaborative care for treating post‐CABG depression. Psychosomatic Medicine 2009;71:217‐30. - PMC - PubMed
Schrader 2005 {published data only}
    1. Cheok F, Schrader G, Banham D, Marker J, Hordacre AL. Identification, course, and treatment of depression after admission for a cardiac condition: rationale and patient characteristics for the Identifying Depression As a Comorbid Condition (IDACC) project. American Heart Journal 2003;146:978‐84. - PubMed
    1. Schrader G, Cheok F, Hordacre AL, Marker J, Wade V. Effect of psychiatry liaison with general practitioners on depression severity in recently hospitalised cardiac patients: a randomised controlled trial. The Medical Journal of Australia 2005;182:272‐6. - PubMed
    1. Wade V, Cheok F, Schrader G, Hordacre AL, Marker J. Depression after cardiac hospitalisation‐‐the Identifying Depression as a Comorbid Condition (IDACC) study. Australian Family Physician 2005;34:985‐9. - PubMed
Stern 1983 {published data only}
    1. Stern MJ, Gorman PA, Kaslow L. The group counseling v exercise therapy study. A controlled intervention with subjects following myocardial infarction. Archives of Internal Medicine 1983;143:1719‐25. - PubMed
Veith 1982 {published data only}
    1. Veith RC, Raskind MA, Caldwell JH, Barnes RF, Gumbrecht G, Ritchie JL. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. The New England Journal of Medicine 1982;306:954‐9. - PubMed
Zeng 2001 {published data only}
    1. Zeng W, Ma H, Liang Q, Dong Y, Ye H, Zhang Y. The influence of antidepressive therapy on short‐term prognosis in elderly patients with unstable angina and depression [Chinese]. Zhonghua Nei Ke Za Zhi 2001;40:809‐10. - PubMed

References to studies awaiting assessment

Malik 2002 {published data only}
    1. Malik NA. Comparison of treatment to influence depression as a risk factor for ischemic heart disease with new generation antidepressants. XII World Congress of Psychiatry, Yokohama, Japan. Aug 24 9, 2002.

References to ongoing studies

SPIRR‐CAD 2008 {published data only}
    1. ISRCTN76240576. A Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease ‐ a randomised controlled trial (SPIRR‐CAD). http://www.controlled‐trials.com/isrctn/pf/76240576 (accessed 10 August 2009).
UPBEAT 2007 {published data only}
    1. Blumenthal JA, Sherwood A, Rogers SD, Babyak MA, Doraiswamy PM, Watkins L, et al. Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study‐‐rationale, design, and methodological issues. Clinical Trials 2007;4:548‐59. - PMC - PubMed

Additional references

Alpert 2000
    1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined‐‐a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Journal of the American College of Cardiology 2000;36:959‐69. - PubMed
Antman 2004
    1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;44:e82‐e292. - PubMed
APA 1994
    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM‐IV. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
Barth 2004
    1. Barth J, Schumacher M, Herrmann‐Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta‐analysis. Psychosomatic Medicine 2004;66:802‐13. - PubMed
Baumeister 2005
    1. Baumeister H, Balke K, Härter M. Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. Journal of Clinical Epidemiology 2005;58:1090‐100. - PubMed
Baumeister 2007
    1. Baumeister H, Härter M. Mental disorders in patients with obesity in comparison with healthy probands. International Journal of Obesity 2007;31:1155‐64. - PubMed
Baumeister 2008
    1. Baumeister H, Morar V. The impact of clinical significance criteria on subthreshold depression prevalence rates. Acta Psychiatrica Scandinavica 2008;118:443‐50. - PubMed
Baumeister 2009a
    1. Baumeister H, Maercker A, Casey P. Adjustment disorders with depressed mood: A critique of its DSM‐IV and ICD‐10 conceptualization and recommendations for the future. Psychopathology 2009;42:139‐47. - PubMed
Baumeister 2009b
    1. Baumeister H, Kufner K. It is time to adjust the adjustment disorder category. Current Opinion in Psychiatry 2009;22:409‐12. - PubMed
Baumeister 2010a
    1. Baumeister H, Kriston L, Bengel J, Härter M. High agreement of self‐report and physician‐diagnosed somatic conditions yields limited bias in examining mental‐physical comorbidity. Journal of Clinical Epidemiology 2010;63:558‐65. - PubMed
Baumeister 2010b
    1. Baumeister H. A clinical significance criterion is essential for diagnosing subthreshold depression. American Journal of Psychiatry 2010;167:866. - PubMed
Baumeister 2010c
    1. Baumeister H, Parker G. A second thought on subtyping major depression. Psychotherapy & Psychosomatics 2010;79:388‐9. - PubMed
Baumeister 2011a
    1. Baumeister H, Hutter N, Bengel J, Härter M. Quality of life in somatically ill persons with comorbid mental disorders: a systematic review and meta‐analysis. Psychotherapy and Psychosomatics 2011; Vol. 80:275‐86. - PubMed
Baumeister 2011b
    1. Baumeister H. Inappropriate prescriptions of antidepressant drugs in patients with subthreshold to mild depression: time for the evidence to become practice. Journal of Affective Disorders 2011. [DOI: ] - PubMed
Bech 2010
    1. Bech P. Is the antidepressive effect of second‐generation antidepressants a myth?. Psychological Medicine 2010;40:181‐6. - PubMed
Budde 2005
    1. Budde T, Breithardt G. Coronary Artery Disease [Koronare Herzkrankheit]. In: Greten H editor(s). Innere Medizin: Verstehen‐Lernen‐Anwenden. Stuttgart: Thieme, 2005:34‐54.
Cuijpers 2008a
    1. Cuijpers P, Straten A, Andersson G, Oppen P. Psychotherapy for depression in adults: a meta‐analysis of comparative outcome studies. Journal of Consulting and Clinical Psychology 2008;76:909‐22. - PubMed
Cuijpers 2008b
    1. Cuijpers P, Straten A, Andersson G, Oppen P. Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta‐analysis of comparative studies. Journal of Clinical Psychiatry 2008;69:1675‐85. - PubMed
Cuijpers 2010
    1. Cuijpers P, Straten A, Bohlmeijer E, Hollon SD, Andersson G. The effects of psychotherapy for adult depression are overestimated: a meta‐analysis of study quality and effect size. Psychological Medicine 2010;40:211‐23. - PubMed
Davidson 2006
    1. Davidson KW, Kupfer DJ, Bigger JT, Califf RM, Carney RM, Coyne JC, et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report. Annals of Behavioral Medicine 2006;32:121‐6. - PubMed
Davison 2003
    1. Davison GC, Neale JM. Abnormal Psychology. New York: John Wiley & Sons, 2003.
De Maat 2007
    1. Maat SM, Dekker J, Schoevers RA, Jonghe F. Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta‐analysis. European Psychiatry 2007;22:1‐8. - PubMed
Dickens 2008
    1. Dickens C, McGowan L, Percival C, Tomenson B, Cotter L, Heagerty A, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosomatic Medicine 2008;70:450‐5. - PubMed
Fournier 2010
    1. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity. A patient‐level meta‐analysis. JAMA 2010;303:47‐53. - PMC - PubMed
Fox 2006
    1. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, et al. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. European Heart Journal 2006;27:1341‐81. - PubMed
Frasure‐Smith 2000
    1. Frasure‐Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, et al. Depression and health‐care costs during the first year following myocardial infarction. Journal of Psychosomatic Research 2000;48:471‐8. - PubMed
Frasure‐Smith 2003
    1. Frasure‐Smith N, Lesperance F. Depression and other psychological risks following myocardial infarction. Archives of General Psychiatry 2003;60:627‐36. - PubMed
Harnett 2010
    1. Harnett P, O'Donovan A, Lambert MJ. The dose response relationship in psychotherapy: implications for social policy. Clinical Psychologist 2010;14:39‐44.
Herrmann‐Lingen 2006
    1. Herrmann‐Lingen C, Buss U. Anxiety and depression in patients with coronary heart disease. In: Jordan J, Bardé B, Zeiher AM editor(s). Contributions toward evidence‐based psychocardiology: a systematic review of the literature. Washington, DC: American Psychological Association, 2006:125‐57.
Higgins 2008
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008.
Härter 2007a
    1. Härter M, Baumeister H. Etiology of mental disorders in chronic somatic diseases [Ätiologie psychischer Störungen bei chronischen körperlichen Erkrankungen]. In: Härter M, Baumeister H, Bengel J editor(s). Psychische Störungen bei körperlichen Erkrankungen. Heidelberg: Springer, 2007:1‐13.
Härter 2007b
    1. Härter M, Baumeister H, Reuter K, Jacobi F, Höfler M, Bengel J, et al. Increased 12‐month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychotherapy and Psychosomatics 2007;6:354‐60. - PubMed
Joynt 2003
    1. Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biological Psychiatry 2003;54:248‐61. - PubMed
Lefebvre 1996
    1. Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomized controlled trials in EMBASE. Fourth International Cochrane Colloquium, Adelaide, Australia. 20‐24 October 1996.
Lichtenberg 2010
    1. Lichtenberg P, Belmaker RH. Subtyping Major Depressive Disorder. Psychotherapy & Psychosomatics 2010;79:131‐5. - PubMed
Lichtman 2008
    1. Lichtman JH, Bigger JT, Blumenthal JA, Frasure‐Smith N, Kaufmann PG, Lesperance F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American HeartAssociation Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008;118:1768‐75. - PubMed
Moher 1999
    1. Moher D, Cook DJ, Jadad AR. Assessing the quality of reports of randomised trials: implications for the conduct of meta‐analyses. Health Technology Assessment 1999;29:823‐32. - PubMed
Musselman 1998
    1. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Archives of General Psychiatry 1998;55:580‐92. - PubMed
Nemeroff 2003
    1. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. PNAS 2003;100:14293‐96. - PMC - PubMed
NICE 2009
    1. National Institute for Health and Clinical Excellence. Depression: the treatment and management of depression in adults (update). Clinical Guideline 90 2009. http://guidance.nice.org.uk/CG90 (accessed 26 July 2011). - PubMed
Ormel 2007
    1. Ormel J, Korff M, Burger H, Scott K, Demyttenaere K, Huang YQ, et al. Mental disorders among persons with heart disease ‐ results from World Mental Health surveys. General Hospital Psychiatry 2007;29:325‐34. - PMC - PubMed
Pigott 2010
    1. Pigott HE, Leventhal AM, Alter GS, Boren JJ. Efficacy and effectiveness of antidepressants: current status of research. Psychotherapy and Psychosomatics 2010;79:267‐79. - PubMed
Rayner 2010
    1. Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M. Antidepressants for depression in physically ill people. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD007503.pub2] - DOI - PubMed
Rees 2004
    1. Rees K, Bennett P, West R, Davey Smith G, Ebrahim S. Psychological interventions for coronary heart disease. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD002902.pub2] - DOI - PMC - PubMed
Rudisch 2003
    1. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biological Psychiatry 2003;54:227‐40. - PubMed
Sadock 2009
    1. Sadock BJ, Sadock VA, Ruiz P (eds). Kaplan & Sadock’s comprehensive textbook of psychiatry. 9th Edition. Philadelphia, Pa, London: Lippincott Williams & Wilkins, 2009.
Skala 2006
    1. Skala JA, Freedland KE, Carney RM. Coronary heart disease and depression: A review of recent mechanistic research. Canadian Journal of Psychiatry 2006;51:738‐45. - PubMed
Taylor 2008
    1. Taylor D. Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety. Acta Psychiatrica Scandinavica 2008;118:434‐42. - PubMed
Thombs 2006
    1. Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, et al. Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine 2006;21:30‐8. - PMC - PubMed
Turner 2008
    1. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. The New England Journal of Medicine 2008;358:252‐60. - PubMed
Unützer 2002
    1. Unutzer J, Katon W, Callahan CM, Williams JW Jr, Hunkeler E, Harpole L, et al. Collaborative care management of late‐life depression in the primary care setting: a randomized controlled trial. JAMA 2002;288:2836‐45. - PubMed
Van Straten 2010
    1. Straten A, Geraedts A, Verdonck‐de Leeuw I, Andersson G, Cuijpers P. Psychological treatment of depressive symptoms in patients with medical disorders: A meta‐analysis. Journal of Psychosomatic Research 2010;69:23‐32. - PubMed
Wakefield 2010
    1. Wakefield JC, Schmitz MF, Baer JC. Does the DSM‐IV clinical significance criterion for major depression reduce false positives? Evidence from the National Comorbidity Survey Replication. American Journal of Psychiatry 2010;167:298‐304. - PubMed
WHO 1992
    1. World Health Organization. The ICD‐10 Classification of Mental and Behavioral Disorders. Clinical description and diagnostic guidelines. 10th Edition. Geneva: World Health Organization, 1992.
Whooley 2008
    1. Whooley MA, Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008;300:2379‐88. - PMC - PubMed
Ziegelstein 2000
    1. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Archives of Internal Medicine 2000;160:1818‐23. - PubMed

MeSH terms

Substances